Arecor, GSK sign licensing deal
The companies will work together for the development of new approaches to improve administration of several vaccines in development. As per the terms of the agreement, Arecor licenses
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.